Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis

Infective endocarditis (IE) is characterized by high rates of in-hospital death, and Staphylococcus aureus infection predicts a worse prognosis. We aimed to assess if admission inflammatory biomarkers (white blood cell – WBC – count, C-reactive protein — CRP, and procalcitonin) are informative on mi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cardiology 2020-02, Vol.301, p.190-194
Hauptverfasser: Tascini, Carlo, Aimo, Alberto, Arzilli, Chiara, Sbrana, Francesco, Ripoli, Andrea, Ghiadoni, Lorenzo, Bertone, Chiara, Passino, Claudio, Attanasio, Vittorio, Sozio, Emanuela, Taddei, Eleonora, Murri, Rita, Fantoni, Massimo, Paciosi, Francesco, Francisci, Daniela, Pasticci, Maria Bruna, Pallotto, Carlo, Di Caprio, Giovanni, Carozza, Antonio, Maffei, Stefano, Emdin, Michele
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Infective endocarditis (IE) is characterized by high rates of in-hospital death, and Staphylococcus aureus infection predicts a worse prognosis. We aimed to assess if admission inflammatory biomarkers (white blood cell – WBC – count, C-reactive protein — CRP, and procalcitonin) are informative on microbiological etiology and short-term outcomes. Data from 236 patients admitted for IE from January 2013 to June 2018 were retrieved from a multicenter registry. Fifty-two patients (22%) were infected by S. aureus. WBC, CRP and procalcitonin had area under the curve (AUC) values for S. aureus infection of 0.595, 0.675, and 0.727, respectively. Adding procalcitonin to WBC improved discrimination over WBC alone (p = 0.045), and procalcitonin predicted S. aureus infection independently from the other inflammatory biomarkers and patient characteristics. Patients with WBC ≥ 12,800/mm3, CRP ≥ 130 mg/L, and procalcitonin ≥ 1.7 ng/mL had an almost 20-fold higher risk of S. aureus infection than patients with all biomarkers 
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2019.08.013